Sinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapy

In 2008, the Food and Drugs Administration required manufacturers of TNFalpha antagonists to strengthen their warnings about the risk of serious fungal infections in patients with rheumatoid arthritis (RA). Sinus aspergilloma occurs occasionally in RA patients and can progress to invasive Aspergillu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Arthritis research & therapy 2009-01, Vol.11 (6), p.R164-R164, Article R164
Hauptverfasser:	Leboime, Ariane, Berthelot, Jean-Marie, Allanore, Yannick, Khalil-Kallouche, Lama, Herman, Philippe, Orcel, Philippe, Lioté, Frédéric
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antagonists (Biochemistry) Antibodies, Monoclonal - therapeutic use Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - complications Arthritis, Rheumatoid - drug therapy Aspergillosis - complications Aspergillosis - surgery Aspergillus Care and treatment Complications and side effects Diagnosis Etanercept Health aspects Humans Immunoglobulin G - therapeutic use Infliximab Middle Aged Paranasal Sinus Diseases - complications Paranasal Sinus Diseases - surgery Patient outcomes Physiological aspects Pulmonary aspergillosis Receptors, Tumor Necrosis Factor - therapeutic use Retrospective Studies Rheumatoid arthritis Risk factors Tumor necrosis factor Tumor Necrosis Factor-alpha - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!